RETROVIRUSES AND ONC GENES IN HUMAN LEUKEMIAS AND LYMPHOMAS NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


RETROVIRUSES AND ONC GENES IN HUMAN LEUKEMIAS AND LYMPHOMAS

Cancer Treat Res; 26:1-25 1985. Unique Identifier : AIDSLINE ICDB/86622115
Westin EH; Wong-Staal F; Gallo RC; Lab. of Tumor Cell Biology, NCI, Bethesda, MD 20205

Abstract: Retroviruses are of special importance in the understanding of the origin and pathogenesis of leukemias and lymphomas of man. Not only are they a major cause of naturally occurring leukemias and lymphomas in several animal species, thus providing useful model systems relating to the cause and development of neoplasias in man, but retroviruses also provide a means to identify and study some cellular genes (so-called onc genes) which are important in cell growth and differentiation and which have been transduced by the acutely transforming retroviruses. It is believed that abnormal expression and/or qualitative modification of the c-onc genes are involved in the molecular pathogenesis of most or even all cancers no matter what the cause. Retroviruses and onc genes in human leukemias and lymphomas are discussed under the following headings: onc genes in leukemogenesis (retroviral derived cellular onc genes; potential transformation genes detected by transfection techniques), and retroviruses in human leukemia-lymphoma (background considerations; growth of mature human T-cells growth factor (TCGF) and the isolation of the first human retroviruses (HTLV); seroepidemiology of HTLV; molecular epidemiology of HTLV-related diseases; in vitro transformation of normal cord blood T-cells by HTLV; possible mechanisms for HTLV transformation). (97 refs)
Keywords: Animal Antibodies, Viral/ANALYSIS Bibliography Cell Line Cell Transformation, Neoplastic Cell Transformation, Viral Gene Amplification Gene Expression Regulation Human HTLV-BLV Viruses/GENETICS/IMMUNOLOGY Leukemia/*GENETICS Lymphoma/*GENETICS *Oncogenes Retroviridae/GENETICS Retroviridae Infections/*GENETICS T-Lymphocytes/MICROBIOLOGY Transformation, Genetic BIBLIOGRAPHY JOURNAL ARTICLE

KWDanimalantibodies,viral/analysisbibliographycelllinecelltransformation,neoplasticcelltransformation,viralgeneamplificationgeneexpressionregulationhumanhtlv-blvviruses/genetics/immunologyleukemia/KWDgeneticslymphoma/KWDgeneticsKWDoncogenesretroviridae/geneticsretroviridaeinfections/KWDgeneticst-lymphocytes/microbiologytransformation,geneticbibliographyjournalarticle
861030
M86A0339

Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .